Today is Physician Family Day, the perfect time to reflect and address any potential burnout symptoms and spend quality time re-engaging with your loved ones.
Risk assessment and management of brain arteriovenous malformations in pregnancy.
New trial results showed statistically significant improvements in overall survival and progression-free survival.
Cancer programs seek to remove barriers to screenings.
Kate White, MD, MPH, and Harold Bays, MD, discuss their hopes for the future of contraception options, affordability, and clinical trials evaluating their efficacy.
Abbott's Lingo and Libre Rio CGM devices, designed for general health and Type 2 diabetes management respectively, receive FDA approval, offering advanced metabolic health tracking for US consumers.
Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.
Understanding the technology behind a newer uterus-sparing option for the management of uterine fibroids.
Data has indicated an increased prevalence of atopic dermatitis among female patients compared to male patients.
Experts discuss management of women’s health including chronic pelvic pain resulting from endometriosis and heavy menstrual bleeding from uterine fibroids. They also discuss ways to help improve patient-provider communications and overcome the normalization associated with non-malignant gynecological conditions.
Oral contraceptive pills are a popular choice for many; providers should understand the options to guide patients effectively.
In this month's Practice Matters column, James D. Keller, MD, MHSA; and Brian K. Iriye, MD, explore the world of value-based care and how it can benefit your practice.
Treatment programs that often use neoadjuvant chemotherapy as a strategy may help prolong survival in patients with advanced ovarian cancer compared with those that infrequently used the tactic, which may reassure patients and providers.
Three esteemed surgeons discuss technology, weighing the pros and cons of existing and newly developed platforms.
Experts discuss the trajectory of CMV awareness and vaccine development efforts.
Here’s why we should be paying special attention to women’s depression treatment.
Experts close their panel on OAB by identifying treatment pathways for patients who have an unsatisfactory response to third-line therapy.
Interventions before and after birth can reduce the rising maternal mortality ratio.
Recommendations for maternity care professionals based on MiPATH.
A meta-analysis of over 1 million pregnant women in China reveals a 30% anemia prevalence, with significant variations across regions, urban and rural areas, and trimesters.
Despite a $350 billion market potential for menopause treatment, a disconnect persists between women and health care providers, highlighting the need for personalized, trust-building strategies.
Halley Crissman, MD, MPH, shares her insight on the ways in which hospital systems reinforce cisnormativity and focal points to address for a more welcoming environment.
When considering the “health” of a medical practice, much of the focus is on financial indicators: missing collections at the time of service, recurring denials, poor claims management and aging patient balances. However, another area needs attention but is often overlooked: patient satisfaction.
The protocol presented here provides an algorithm for the initial evaluation of anemia in pregnancy, with treatment algorithms for the most common causes in pregnancy.
The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.
Correct terms and education can help normalize the conversation for patients.
Women experiencing menopause later in life may face an increased risk of asthma, according to recent research highlighting the impact of hormone levels on respiratory health.
Sweeping policy-level implementation efforts have mandated SDM in other areas of medicine; similar mandates could impact ob/gyn.
Standard chemotherapy has historically been the mainstay of treatment for patients with diagnoses of early-stage TNBC, but there remains an unmet need to identify novel therapies that improve outcomes and, equally important, to discern which patients may benefit from a given treatment.